Diysta Merap medicine for acute and chronic diarrhea (12 packs)

Dosage form Drink
Specifications 12 package box
Ingredient Diosmectite

Ingredient

Thành phần cho 10g

Composition information	Content
Diosmectite	3G

Uses

indications

Diysta Meraplion package medicine is indicated in the following cases:

Treatment of acute diarrhea in children over 2 years old, combined with water supplements and oral electrolytes. Big.

ATC code: A07BC05.

dioscectite has been shown to the clinical pharmacological effect:

Aggregates in the intestinal tract in adults. Diosmectite interacts with glycoprotein of the mucus covering the digestive tract, so it increases the effect of protecting the gastrointestinal mucosa when attacked by strange agents. The drug has high adhesion and adsorption capacity, creating a barrier to protect the gastrointestinal mucosa. The drug is capable of attaching to the bacterial toxin in the intestine, but at the same time it is capable of attaching other drugs to slow down the absorption or loss of effect. Diosmectite does not contrast, does not dye stool and with common doses, diosmectite does not change the physiological shipping time of the intestine.

Dynamic pharmacokinetics

Due to the structure of diosmectite, the drug only acts in the intestines, does not absorb, does not metabolize Dioscectite is excreted through the normal dysfunction of the intestine.

Before taking Diysta Merap medicine for acute and chronic diarrhea (12 packs)

How to use

DiEBYSTA MERAPAPLION packaging medicine for oral use. Squeeze the medicine evenly to get the inner translation of the homogeneous before use.

The amount of medicine in the package can be taken immediately without mixing or can be mixed with a little water before drinking. In children, it is possible to dilute the mixture in the packet with a little water or mix with liquid/thick food such as porridge, fruit jam, pureed food, children's food.

Should take medicine away from meals.

Dosage

Acute diarrhea treatment:

Children over 2 years: 4 packs/day for the first 3 days. Then 2 packs/day for the next 4 days

Adults: Average 3 packs/day for 7 days. In fact, daily dose can double in the early days of treatment.

Other indications:

Adults: Average 3 packs/day.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when overdose?

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

The most unwanted effect during treatment is constipation, with the rate of about 7% in adults and 1% in children. In case of constipation, diosmectite should be stopped. Considering that the use of Diosmectite is necessary, it should be started with a low doses below as a list of unwanted effects of the drug reported from clinical studies & after circulating diosmectite in the market. The frequency is determined based on the following classification: Very common (≥1/10); Common (≥1/100 to

Gastrointestinal disorders:

Common: Constipation.

Uncommon: rare rash.

Rare: urticaria.

Unknown: Hypersensitivity.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Diobysta package is contraindicated in the following cases:

Hypersensitivity to Diosmectite or one of the ingredients of the drug

Caution when using

dioscectite must be used cautiously in patients with a history of severe chronic constipation.

infants and children under 2 years of age should avoid using diosmectite. Treatment recommended in acute diarrhea in this object is oral water rehydration (ORS).

In children over 2 years of age, acute diarrhea must be treated in combination with early use of oral electrolyte (ORS) to avoid dehydration. Diosmectite should be avoided for a long time.

In adults, it is necessary to combine water and electrolytes if this is necessary.

The amount of fluid to be taken by oral or intravenous tract must be adjusted in accordance with the level of diarrhea, age and atopic of the patient.

Patients should be notified of the need:

Take a lot of salty or sweet fluid to complete the loss of fluid due to diarrhea (the need for medium fluid
daily in adults is 2 liters).

When diarrhea, maintain a normal diet:

Except for some foods, especially raw vegetables, fruits, green vegetables, spicy foods, as well as frozen foods or drinks.

Use drugs for women during pregnancy and lactation

Pregnant women

There is no data or limited data (less than 300 pregnant women) on the use of diosmectite during pregnancy.

Animal studies are not enough to conclude about the reproductive toxicity of the drug. Diosmectite is not recommended for pregnant women.

breastfeeding women

Data on the use of diosmectite in women who are breastfeeding is limited.

diosmectite does not recommend use during breastfeeding.

The effect of the drug on driving and operating machinery

dioscectite has no negligible impact or impact on the ability to drive and operate machinery.

Drug interaction

The adsorbent characteristics of diosmectite can affect the speed and/or the level of absorption of other substances, so recommendations should not be used at the same time with other drugs (should be used at least 2 hours away).

Storage

Leave a cool place, avoid light, temperature below 30⁰C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.